Cephalon Inks Deal To Market Fentora In China
This article was originally published in PharmAsia News
Executive Summary
Cephalon has entered into a master services agreement with Beijing Med-Pharm to undertake the registration process for certain Cephalon products in the People's Republic of China, Med-Pharm announced Dec. 11
You may also be interested in...
Cephalon’s Fentora Approved For Breakthrough Cancer Pain
Barr is free to launch generic of Actiq, Fentora’s predecessor.
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).